[Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19]

Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 14;41(3):185-191. doi: 10.3760/cma.j.issn.0253-2727.2020.0002.

[Article in Chinese]

Authors

H Mei¹, Y Hu¹

Affiliation

¹ Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, The Thrombosis and Hemostasis Clinical Medical Research Center of Hubei Province, Wuhan 430022, China.

PMID: 32133825
PMCID: PMC7357924
DOI: 10.3760/cma.j.issn.0253-2727.2020.0002

No abstract available

MeSH terms

Betacoronavirus*
Blood Coagulation Disorders / diagnosis
Blood Coagulation Disorders / etiology*
Blood Coagulation Disorders / therapy
COVID-19
Coronavirus Infections* / complications
Humans
Pandemics*
Pneumonia, Viral* / complications
SARS-CoV-2

Grants and funding

基金项目：国家自然科学基金（81873434、81770132）；华中科技大学2020年新冠肺炎应急专项基金